Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

MHC-restricted Ag85B-specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice.

Komine-Aizawa S, Jiang J, Mizuno S, Hayakawa S, Matsuo K, Boyd LF, Margulies DH, Honda M.

Eur J Immunol. 2019 Sep;49(9):1399-1414. doi: 10.1002/eji.201847988. Epub 2019 Jun 19.

PMID:
31135967
2.

Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.

Tang C, Yamada H, Shibata K, Maeda N, Yoshida S, Wajjwalku W, Ohara N, Yamada T, Kinoshita T, Yoshikai Y.

J Infect Dis. 2008 May 1;197(9):1263-74. doi: 10.1086/586902.

PMID:
18422438
3.

Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.

Rahman S, Magalhaes I, Rahman J, Ahmed RK, Sizemore DR, Scanga CA, Weichold F, Verreck F, Kondova I, Sadoff J, Thorstensson R, Spångberg M, Svensson M, Andersson J, Maeurer M, Brighenti S.

Mol Med. 2012 May 9;18:647-58. doi: 10.2119/molmed.2011.00222.

4.

A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.

Yuan X, Teng X, Jing Y, Ma J, Tian M, Yu Q, Zhou L, Wang R, Wang W, Li L, Fan X.

Appl Microbiol Biotechnol. 2015 Dec;99(24):10587-95. doi: 10.1007/s00253-015-6962-x. Epub 2015 Sep 12.

PMID:
26363555
5.

Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.

Geluk A, van Meijgaarden KE, Franken KL, Drijfhout JW, D'Souza S, Necker A, Huygen K, Ottenhoff TH.

J Immunol. 2000 Dec 1;165(11):6463-71.

6.

A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.

Rai PK, Chodisetti SB, Maurya SK, Nadeem S, Zeng W, Janmeja AK, Jackson DC, Agrewala JN.

J Transl Med. 2018 Oct 11;16(1):279. doi: 10.1186/s12967-018-1653-x.

7.

Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL/6 mice.

Lu Y, Xu Y, Yang E, Wang C, Wang H, Shen H.

Scand J Immunol. 2012 Sep;76(3):271-7. doi: 10.1111/j.1365-3083.2012.02726.x.

8.
9.

Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.

Dai G, Rady HF, Huang W, Shellito JE, Mason C, Ramsay AJ.

Vaccine. 2016 Dec 7;34(50):6267-6275. doi: 10.1016/j.vaccine.2016.10.065. Epub 2016 Nov 4.

10.
11.

Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model.

Platteel ACM, Nieuwenhuizen NE, Domaszewska T, Schürer S, Zedler U, Brinkmann V, Sijts AJAM, Kaufmann SHE.

Front Immunol. 2017 Dec 11;8:1744. doi: 10.3389/fimmu.2017.01744. eCollection 2017.

12.

Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.

Hu Z, Wong KW, Zhao HM, Wen HL, Ji P, Ma H, Wu K, Lu SH, Li F, Li ZM, Shu T, Xu JQ, Lowrie DB, Fan XY.

Mol Ther. 2017 May 3;25(5):1222-1233. doi: 10.1016/j.ymthe.2017.02.018. Epub 2017 Mar 23.

13.

Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against Mycobacterium tuberculosis.

Kou Y, Wan M, Shi W, Liu J, Zhao Z, Xu Y, Wei W, Sun B, Gao F, Cai L, Jiang C.

J Microbiol Biotechnol. 2018 Jun 28;28(6):1022-1029. doi: 10.4014/jmb.1712.12064.

14.

Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.

Hopkins R, Bridgeman A, Bourne C, Mbewe-Mvula A, Sadoff JC, Both GW, Joseph J, Fulkerson J, Hanke T.

Eur J Immunol. 2011 Dec;41(12):3542-52. doi: 10.1002/eji.201141962. Epub 2011 Oct 26.

15.

Immunogenicity of recombinant Mycobacterium bovis bacille Calmette-Guèrin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens.

Mohamud R, Azlan M, Yero D, Alvarez N, Sarmiento ME, Acosta A, Norazmi MN.

BMC Immunol. 2013;14 Suppl 1:S5. doi: 10.1186/1471-2172-14-S1-S5. Epub 2013 Feb 25.

16.

Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice.

Yang E, Gu J, Wang F, Wang H, Shen H, Chen ZW.

Microb Pathog. 2016 Apr;93:1-7. doi: 10.1016/j.micpath.2016.01.006. Epub 2016 Jan 12.

PMID:
26792673
17.

Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.

Yang E, Lu Y, Xu Y, Liang Q, Wang C, Wang H, Shen H.

Microb Pathog. 2014 Apr-May;69-70:53-9. doi: 10.1016/j.micpath.2014.03.011. Epub 2014 Apr 12.

PMID:
24726737
18.
19.

DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.

Dalmia N, Klimstra WB, Mason C, Ramsay AJ.

PLoS One. 2015 Aug 28;10(8):e0136635. doi: 10.1371/journal.pone.0136635. eCollection 2015.

20.

Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.

Liang J, Teng X, Yuan X, Zhang Y, Shi C, Yue T, Zhou L, Li J, Fan X.

Mol Immunol. 2015 Aug;66(2):392-401. doi: 10.1016/j.molimm.2015.04.017. Epub 2015 May 18.

PMID:
25974877

Supplemental Content

Support Center